 |
|
|
| |
DEVELOPMENT OF CCP3, A MORE SENSITIVE CYCLIC CITRULLINATED PEPTIDE ELISA
Rufus W. Burlingame1, Carlos A. von Mühlen2, Andrea L. Piette1, Walter L. Binder1, 1INOVA Diagnostics, Inc., San Diego, CA; 2PUC School of Medicine, Porto Alegre, Brazil
A slide show version of the poster for web viewing.
- Anti-CCP factor including anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF: Impact of including anti-CCP to the diagnostic criteria for early Rheumatoid Arthritis
Rufus W. Burlingame1, Andrea L. Piette1, Ana L. Bender2, Carlos A. von Mühlen2, Henrique L. Staub2 and Inês G. Silveira2, 1INOVA Diagnostics, Inc., San Diego, CA, USA; 2Department of Rheumatology, Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil
- DETECTION OF ANTI-CCP AND DIAGNOSIS OF RHEUMATOID ARTHRITIS
Rufus W. Burlingame1, Robert Morris2, Allan Metzger2, Carlos von Mühlen3, Mark H. Wener4, Carol L. Peebles1, Andrea L Piette1, Walter L. Binder1
1INOVA Diagnostics, Inc., San Diego, CA; 2Rheumatology Diagnostics Laboratory, Los Angeles, CA; 3PUC School of Medicine, Porto Alegre, Brazil; 4University of Washington Medical Center, Seattle, WA
|
| |
|
|
|
|
|
